A Phase II Study Evaluating AGuIX® Nanoparticles in Combination With Stereotactic Radiation for Oligo Brain Metastases
Latest Information Update: 10 Jun 2021
Price :
$35 *
At a glance
- Drugs Gadolinium chelated polysiloxane based nanoparticle (Primary)
- Indications Brain metastases; Solid tumours
- Focus Therapeutic Use
- Acronyms NANOSTEREO
- 10 Jun 2021 Status changed from active, no longer recruiting to discontinued after a negative result delivered by the CPP for a substantial modification of the protocol.
- 17 Mar 2021 New trial record